Nanosilver-Based antibacterial agents for food safety

Food Poisoning: Outbreaks, Bacterial Sources and Adverse Health Effects

Volumn , Issue , 2014, Pages 35-62

  Dasari, Thabitha P S ^a   Deng, Hua ^a   McShan, Danielle ^a   Yu, Hongtao ^a  

^a JACKSON STATE UNIVERSITY   (United States)

Author keywords

Antibiotics; Food Safety; Microbial Pathogens; Nanosilver; Silver Nanoparticle

Indexed keywords

EID: 84955685322     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (210)

1. Meng, J; Doyle, MP. Emerging and evolving microbial foodborne pathogens, Bull. Inst. Pasteur, 1998, 96, 151-163.
2. Scallan, E; Hoekstra, RM; Angulo, FJ; Tauxe, RV; Widdowson, M.-A; Roy, SL; Jones, JL; Griffin, PM. Foodborne illness acquired in the United States - major pathogens, Emerg. Infect. Dis., 2011, 17, 7-15.
3. Skovgaard, N. New trends in emerging pathogens, Int. J. Food. Microbiol., 2007, 120, 217-224.
4. Tauxe, RV. Emerging foodborne pathogens, Int. J. Food. Microbiol., 2002, 78, 31-41.
5. Slifko, TR; Smith, HV; Rose, JB. Emerging parasite zoonoses associated with water and food, Int. J. Parasitol., 2000, 30, 1379-1393.
6. Byarugaba, DK. Antimicrobial resistance in developing countries and responsible risk factors, Int. J. Antimicrob. Agents, 2004, 24, 105-110.
7. Mayrhofer, S; Paulsen, P; Smulders, FJ; Hilbert, F. Antimicrobial resistance profile of five major food-borne pathogens isolated from beef, pork and poultry, Int. J. Food. Microbiol., 2004, 97, 23-29.
8. Silbergeld, EK; Graham, J; Price, LB. Industrial food animal production, antimicrobial resistance, and human health, Annu. Rev. Pub. Health., 2008, 29, 151-169.
9. Singer, RS; Finch, R; Wegener, HC; Bywater, R; Walters, J; Lipsitch, M. Antibiotic resistance - the interplay between antibiotic use in animals and human beings, Lancet. Infect. Dis., 2003, 3, 47-51.
10. Sorum, H; Labee Lund, TM. Antibiotic resistance in food-related bacteria: a result of interfering with the global web of bacterial genetics, Int. J. Food. Microbiol., 2002, 78, 43-56.
11. Su, L-H; Chiu, C-H; Chu, C; Ou, JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge, Clin. Infect. Dis., 2004, 39, 546-551.
12. Threlfall, E. J. Antimicrobial drug resistance in Salmonella: problems and perspectives in food - and water- borne infections, FEMS Microbiol. Rev., 2002, 26, 141-148.
13. Threlfall, EJ; Ward, LR; Frost, JA; Willshaw, GA. The emergence and spread of antibiotic resistance in food-borne bacteria, Int. J. Food. Microbiol., 2000, 62, 1-5.
14. White, DG; Zhao, S; Simjee, S; Wagner, DD; McDermott, PF. Antimicrobial resistance of foodborne pathogens, Microbe. Infect., 2002, 4, 405-412.
15. Keiser, J; Utzinger, J. Emerging foodborne trematodiasis, Emerg. Infect. Dis., 2005, 11, 1507-1517.
16. Lynch, M; Painter, J; Woodruff, R; Braden, C. "Surveillance for Foodborne - Disease Outbreaks: United States, 1998-2002," Center for Disease Control and Prevention, 2006.
17. Gorman, R; Bloomfield, S; Adley, CC. A study of cross-contamination of food-borne pathogens in the domestic kitchen in the Republic of Ireland, Int. J. Food. Microbiol., 2002, 76, 143-150.
18. Adak, GK; Long, SM; O'Brien, SJ. Trends in indigenous foodborne disease and deaths, England and Wales, 1992 to 2000, Gut, 2002, 51, 832-841.
19. Ayers, LT; Williams, IT; Gray, S; Griffin, PM; Hall, AJ. Surveillance for foodborne disease outbreaks-United States, 2006, Morbid. Mortal. Week. Rep., 2009, 58, 609-615.
20. Olsen, SJ; MacKinnon, LC; Goulding, JS; Bean, NH; Slutsker, L. "Surveillance for foodborne-disease outbreaks - United States, 1993-1997," CDC, 2000.
21. Scharff, RL. Georgetown University: Washington, DC, 2010; Vol., 2014.
22. Tauxe, RV. Emerging foodborne diseases: an evolving public health challenge, Emerg. Infect. Dis., 1997, 3, 425-434.
23. Tauxe, RV. Surveillance and investigation of foodborne diseases; roles for public health in meeting objectives for food safety, Food Control, 2002, 13, 363-369.
24. Van de Venter, T. In Food, Nutrition, and Agriculture; Department of Health, Republic of South Africa: South Africa, 2000, Vol., 2014.
25. Swaminathan, B; Gerner-Smidt, P; Ng, L-K; Lukinmaa, S; Kam, K-M; Rolando, S; Gutierrez, EP; Binsztein, N. Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases, Foodborne Pathog. Dis., 2006, 3, 36-50.
26. Cao, J; Kursten, D; Schneider, S; Knauer, A; Gunther, PM; Kohler, JM. Uncovering toxicological complexity by multi-dimensional screenings in microsegmented flow: modulation of antibiotic interference by nanoparticles, Lab. Chip, 2012, 12, 474-484.
27. Chopra, I; Roberts, M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance, Microbiol. Mol. Biol. Rev., 2001, 65, 232-260.
28. Engberg, J; Aarestrup, FM; Taylor, DE; Gerner-Smidt, P; Nachamkin, I. Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates, Emerg. Infect. Dis., 2001, 7, 24-34.
29. Cohen, ML. Changing patterns of infectious disease; Nature, 2000, 406, 762-767.
30. Wilson, BA; Salyers, AA; Whitt, DD; Winkler, ME. Bacterial Pathogenesis: A Molecular Approach; American Society for Microbiology (ASM): Washington DC, 2011.
31. Coates, A; Hu, Y; Bax, R; Page, C. The future challenges facing the development of new antimicrobial drugs, Nat. Rev. Drug. Discov., 2002, 1, 895-910.
32. Fischbach, MA; Walsh, CT. Antibiotics for Emerging Pathogens; Science, 2009, 325, 1089-1093.
33. Huh, AJ; Kwon, YJ. Nanoantibiotics: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, J. Control. Release, 2011, 156, 128-45.
34. CDC. Center for Disease Control and Prevention: Atlanta, GA, 2011, Vol., 2014.
35. CDC In CDC, 2011 Estimates: Findings; Center for Disease Control and Prevention: Atlanta, GA, 2011, Vol., 2014.
36. Kang, S; Pinault, M; Pfefferle, LD; Elimelech, M. Single-walled carbon nanotubes exhibit strong antimicrobial activity; Langmuir, 2007, 23, 8670-8673.
37. Lines, MG. Nanomaterials for practical functional uses, J. Alloy Compd., 2008, 449, 242-245.
38. Dingman, J. Nanotechnology: Its Impact On Food Safety, J. Environ. Health, 2008, 70, 47-50.
39. Sozer, N; Kokini, JL. Nanotechnology and its applications in the food sector, Trend Biotechnol., 2009, 27, 82-89.
40. Magnuson, BA; Jonaitis, TS; Card, JW. A Brief Review of the Occurrence, Use, and Safety of Food - Related Nanomaterials, J. Food. Sci., 2011, 76, R126-R133.
41. Duncan, TV. Applications of nanotechnology in food packaging and food safety: Barrier materials, antimicrobials and sensors, J. Colloid. Interface Sci., 2011, 363, 1-24.
42. Marambio-Jones, C; Hoek, EMV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment, J. Nanopart. Res., 2010, 12, 1531-1551.
43. Azam, A; Ahmed, AS; Oves, M; Khan, MS; Habib, SS; Memic, A. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study, Int. J. Nanomed., 2012, 7, 6003-6009.
44. Rai, M; Yadav, A; Cioffi, N. In Nano-Antimicrobials: Progress and Prospects, Cioffi, N. Rai, M., Eds; Springer-Verlag: Berlin Heidelberg, 2012.
45. Lara, HH; Ayala-Nunez, NV; Turrent, Ld CI; Padilla, CR. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria, World J. Microbiol. Biotech., 2010, 26, 615-621.
46. Li, P; Li, J; Wu, C; Wu, Q; Li, J. Synergistic antibacterial effects of b-lactam antibiotic combined with silver nanoparticles, Nanotechnology, 2005, 16, 1912.
47. Fayaz, AM; Balaji, K; Girilal, M; Yadav, R; Kalaichelvan, PT; Venketesan, R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria, Nanomed. Nanotech. Biol. Med., 2010, 6, 103-109.
48. Bolla, J-M; Alibert-Franco, S; Handzlik, J; Chevalier, J; Mahamoud, A; Boyer, G; Kieć-Kononowicz, K; Pagès, J-M. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria; FEBS Lett., 2011, 585, 1682-1690.
49. Ghosh, S; Patil, S; Ahire, M; Kitture, R; Kale, S; Pardesi, K; Cameotra, SS; Bellare, J; Dhavale, DD; Jabgunde, A; Chopade, B. Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents, Int. J. Nanomed., 2012, 7, 483-496.
50. Chen, X; Niyonsaba, F; Ushio, H; Okuda, D; Nagaoka, I; Ikeda, S; Okumura, K; Ogawa, H. Synergistic effect of antibacterial agents human b-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli, J. Dermatol. Sci., 2005, 40, 123-132.
51. Allahverdiyev, AM; Kon, KV; Abamor, ES; Bagirova, M; Rafailovich, M. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents, Expert. Rev. Anti-Infect. Ther., 2011, 9, 1035-1052.
52. Priya Dhas, S; Mukherjee, A; Chandrasekaran, N. Synergistic effect of biogenic silver nanocolloid in combination with antibiotics: A potent therapeutic agent, Int. J. Pharm. Pharmaceut. Sci., 2013, 5, 292-295.
53. Abeylath, SC; Turos, E. Drug delivery approaches to overcome bacterial resistance to beta-lactam antibiotics; Expert. Opin. Drug. Deliv., 2008, 5, 931-949.
54. Musee, N; Thwala, M; Nota, N. The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants, J. Environ. Monit., 2011, 13, 1164-1183.
55. Seil, JT; Webster, TJ. Antimicrobial applications of nanotechnology: methods and literature, Int. J. Nanomed., 2012, 7, 2767-2781.
56. Ramani, M; Ponnusamy, S; Muthamizhchelvan, C. Preliminary investigations on the antibacterial activity of zinc oxide nanostructures, J. Nanopart. Res., 2013, 15, 1557.
57. Dar, MA; Ingle, A; Rai, M. Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics, Nanomed, Nanomed. Biol. Med., 2012, 9, 105-110.
58. Gajbhiye, M; Kesharwani, J; Ingle, A; Gade, A; Rai, M. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole, Nanomed. Nanotechnol. Biol. Med., 2009, 5, 382-386.
59. Kora, AJ; Rastogi, L. Enhancement of Antibacterial Activity of Capped Silver Nanoparticles in Combination with Antibiotics, on Model Gram-Negative and Gram-Positive Bacteria, Bioinorgan. Chem. Appl., 2013, 2013, 1-7.
60. Rajawat, S; Qureshi, MS. Study Comparative on Bactericidal Effect of Silver Nanoparticles, Synthesized Using Green Technology, in Combination with Antibiotics on Salmonella typhi, J. Biomed. Nanotechnol., 2012, 3, 480-485.
61. Kalan, L; Wright, GD. Antibiotic adjuvants: multicomponent anti-infective strategies, Exp. Rev. Mol. Med., 2011, 13, e5.
62. Reidy, B; Haase, A; Luch, A; Dawson, KA; Lynch, I. Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications, Materials, 2013, 6, 2295-2350.
63. Duran, N; Marcato, PD; Conti, RD; Alves, OL; Costa, F; Brocchi, M. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action, J. Brazil. Chem. Soc., 2010, 21, 949-959.
64. Hajipour, MJ; Fromm, KM; Akbar Ashkarran, A; Jimenez de Aberasturi, D; Larramendi, IRd; Rojo, T; Serpooshan, V; Parak, WJ; Mahmoudi, M. Antibacterial properties of nanoparticles, Trends. Biotechnol., 2012, 30, 499-511.
65. Hwang, I-s; Hwang, JH; Choi, H; Kim, K-J; Lee, DG. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved, J. Med. Microbiol., 2012, 61, 1719-1726.
66. Leid, JG; Ditto, AJ; Knapp, A; Shah, PN; Wright, BD; Blust, R; Christensen, L; Clemons, CB; Wilber, JP; Young, GW; Kang, AG; Panzner, MJ; Cannon, CL; Yun, YH; Youngs, WJ; Seckinger, NM; Cope, EK. vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria, J. Antimicrob. Chemother., 2011, 67, 138-148.
67. Rai, RV; Bai, JA. In Science against microbial pathogens: Communicating current research and technological advances; Méndez-Vilas, A., Ed., Formatex Research Center: Spain, 2011, Vol. 3.
68. Chernousova, S; Epple, M. Silver as antibacterial agent: ion, nanoparticle, and metal, Angew. Chem., 2012, 52, 1636-1653.
69. Gade, A; Ingle, A; Whiteley, C; Rai, M. Mycogenic metal nanoparticles: progress and applications, Biotechnol. Lett., 2010, 32, 593-600.
70. Height, MJ. In FIFRA scientific advisory panel (SAP) open consultation meeting; Silver Nanotechnology Working Group (SNWG), 2009, Vol., 2014.
71. Llorens, A; Lloret, E; Picouet, PA; Trbojevich, R; Fernandez, A. Metallic-based micro and nanocomposites in food contact materials and active food packaging, Trends. Food Sci. Tech., 2012, 24, 19-29.
72. Slawson, RM; Lee, H; Trevors, JT. Bacterial interactions with silver, Biol. Metal, 1990, 3, 151-154.
73. Appendini, P; Hotchkiss, JH. Review of antimicrobial food packaging, Innov. Food Sci. Emerg. Technol., 2002, 3, 113-126.
74. Azeredo, H. Nanocomposites for food packaging applications, Food Res. Int., 2009, 42, 1240-1253.
75. Bata-Vidács, I; Adányi, N; Beczner, J; Farkas, J; Székács, A. In Microbial pathogens and strategies for combating them: science, technology and education; Méndez-Vilas, A., Ed., Formatex: Spain, 2013.
76. Bouwmeester, H; Dekkers, S; Noordam, MY; Hagens, WI; Bulder, AS; De Heer, C; Ten Voorde, SE; Wijnhoven, SW; Marvin, HJ; Sips, AJ. Review of health safety aspects of nanotechnologies in food production, Regulat. Toxicol. Pharmacol., 2009, 53, 52-62.
77. de Azeredo, HMC. Antimicrobial nanostructures in food packaging, Trends. Food. Sci. Tech, 2009, 30, 56-69.
78. Kim, JS; Kuk, E; Yu, KN; Kim, J-H; Park, SJ; Lee, HJ; Kim, SH; Park, YK; Park, YH; Hwang, C-Y; Kim, Y-K; Lee, Y-S; Jeong, DH. Antimicrobial effects of silver nanoparticles, Nanomed. Nanotechnol. Biol. Med., 2007, 3, 95-101.
79. Morones, JR; Elechiguerra, JL; Camacho, A; Holt, K; Kouri, JB; Ramirez, JT; Yacaman, MJ. The bactericidal effect of silver nanoparticles, Nanotechnology, 2005, 16, 2346-2353.
80. Atiyeh, BS; Costagliola, M; Hayek, SN; Dibo, SA. Effect of silver on burn wound infection control and healing: review of the literature, Burns, 2007, 33, 139-148.
81. Baker, C; Pradhan, A; Pakstis, L; Pochan, DJ; Shah, SI. Synthesis and antibacterial properties of silver nanoparticles, J. Nanosci. Nanotech., 2005, 5, 244-249.
82. Barud, HS; Regiani, T; Marques, RFC; Lustri, WR; Messaddeq, Y; Ribeiro, SJL. Antimicrobial bacterial cellulose-silver nanoparticles composite membranes, J. Nanomat., 2011, 2011, 10.
83. Birla, SS; Tiwari, VV; Gade, AK; Ingle, AP; Yadav, AP; Rai, MK. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus, Lett. Appl. Microbiol., 2009, 48, 173-179.
84. Castellano, JJ; Shafii, SM; Ko, F; Donate, G; Wright, TE; Mannari, RJ; Payne, WG; Smith, DJ; Robson, MC. Comparative evaluation of silver-containing antimicrobial dressings and drugs, Int. Wound J., 2007, 4, 114-122.
85. Chaloupka, K; Malam, Y; Seifalian, AM. Nanosilver as a new generation of nanoproduct in biomedical applications, Trends Biotechnol., 2010, 28, 580-588.
86. Chen, X; Schluesener, H. Nanosilver: a nanoproduct in medical application, Toxicol. Lett., 2008, 176, 1-12.
87. Silver, S; Phung, LT; Silver, G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds, J. Ind. Microbiol. Biotechnol., 2006, 33, 627-634.
88. Klasen, H. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver; Burns, 2000, 26, 131-138.
89. Modak, SM; Sampath, L; Fox Jr, CL Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds, J. Burn. Care. Res., 1988, 9, 359-363.
90. Dorny, P; Praet, N; Deckers, N; Gabriel, S. Emerging food-borne parasites, Vet. Parasitol., 2009, 163, 196-206.
91. Velusamy, V; Arshak, K; Korostynska, O; Oliwa, K; Adley, C. An overview of foodborne pathogen detection: in the perspective of biosensors, Biotechnol. Adv., 2010, 28, 232-254.
92. Farber, JM; Peterkin, PI. Listeria monocytogenes, a Food-Borne Pathogen, Microbiol. Rev., 1991, 55, 476.
93. Mead, PS; Slutsker, L; Dietz, V; McCaig, LF; Bresee, JS; Shapiro, C; Griffin, PM; Tauxe, RV. Food-related illness and death in the United States; Emerg. Infect. Dis., 1999, 5, 607-625.
94. Montville, TJ; Matthews, KR; Kniel, KE. Food Microbiology: An Introduction, 3rd ed; ASM Press, 2012.
95. Newell, DG; Koopmans, M; Verhoef, L; Duizer, E; Aidara-Kane, A; Sprong, H; Opsteegh, M; Langelaar, M; Threfall, J; Scheutz, F; Giessen, Jvd; Kruse, H. Foodborne diseases - the challenges of 20 years ago still persist while new ones continue to emerge, Int. J. Food Microbiol., 2010, 139, S3-S15.
96. Schlundt, J. New directions in foodborne disease prevention, Int. J. Food Microbiol., 2002, 78, 3-17.
97. Swaminathan, B; Barrett, TJ; Hunter, SB; Tauxe, RV. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States; Emerg. Infect. Dis., 2001, 7, 382.
98. Rangel, JM; Sparling, PH; Crowe, C; Griffin, PM; Swerdlow, DL. Epidemiology of Escherichia coli O157: H7 outbreaks, United States, 1982-2002, Emerg. Infect. Dis., 2005, 11, 603-609.
99. Rai, MK; Deshmukh, SD; Ingle, AP; Gade, AK Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria, J. Appl. Microbiol., 2012, 112, 841-852.
100. Velusamy, V; Arshak, K; Korostynska, O; Oliwa, K; Adley, C. An overview of foodborne pathogen detection: in the perspective of biosensors, Biotech. Adv., 2010, 28, 232-254.
101. CDC In Morbidity and Mortality Weekly Report (MMWR); Center for Disease Control and Prevention: Atlanta, GA, 2013, Vol., 2014.
102. Siegrist, M; Stampfli, N; Kastenholz, H; Keller, C. Perceived risks and perceived benefits of different nanotechnology foods and nanotechnology food packaging, Appetite, 2008, 51, 283-290.
103. Kalpana, SR; Anshul, S; Rao, NH. Nanotechnology in food processing sector-An assessment of emerging trends, J. Food Sci. Technol., 2013, 50, 831-841.
104. Schierholz, JM; Yücel, N; Rump, AF; Beuth, J; Pulverer, G. Antiinfective and encrustation - inhibiting materials - myth and facts, Int. J. Antimicrob. Agent, 2002, 19, 511-516.
105. Chau, C-F; Wu, S-H; Yen, G-C. The development of regulations for food nanotechnology, Trends Food Sci. Tech., 2007, 18, 269-280.
106. Mahalik, NP; Nambiar, AN. Trends in food packaging and manufacturing systems and technology; Trends. Food. Sci. Tech., 2010, 21, 117-128.
107. Quintavalla, S; Vicini, L. Antimicrobial food packaging in meat industry, Meat Sci., 2002, 62, 373-380.
108. Lazcka, O; Campo, F; Munoz, FX. Pathogen detection: a perspective of traditional methods and biosensors, Biosensors and Bioelectronics, 2007, 22, 1205-1217.
109. Ge, B; Meng, J. Advanced Technologies for Pathogen and Toxin Detection in Foods: Current applications and Future Directions, JALA, 2009, 14, 235-241.
110. Van Dorst, B; Mehta, J; Bekaert, K; Rouah-Martin, E; De Coen, W; Dubruel, P; Blust, R; Robbens, J. Recent advances in recognition elements of food and environmental biosensors: a review; Biosens., Bioelectron., 2010, 26, 1178-1194.
111. Su, W; Lin, M; Lee, H; Cho, M; Choe, W-S; Lee, Y. Determination of endotoxin through an aptamer-based impedance biosensor, Biosens. Bioelectron., 2012, 32, 32-36.
112. Singh, S; Chaubey, A; Malhotra, B. D. Amperometric cholesterol biosensor based on immobilized cholesterol esterase and cholesterol oxidase on conducting polypyrrole films, Anal. Chim. Acta., 2004, 502, 229-234.
113. Singh, A; Poshtiban, S; Evoy, S. Recent advances in bacteriophage based biosensors for food-borne pathogen detection, Sensors, 2013, 13, 1763-1786.
114. Hughes, SI; Dasary, SSR; Singh, AK; Glenn, Z; Jamison, H; Ray, PC; Yu, H. Sensitive and selective detection of trivalent chromium using hyper Rayleigh scattering with 5, 5?-dithio-bis-(2-nitrobenzoic acid)-modified gold nanoparticles, Sens. Actuat. B: Chem., 2013, 178, 514-519.
115. Ray, PC; Yu, H; Fu, PP. Nanogold-based sensing of environmental toxins: excitement and challenges, J. Environ. Sci. Health C, 2011, 29, 52-89.
116. Fan, Z; Khan, SA; Dai, X; Tchounwou, C; Lu, Y; Ray, PC. Theranostic Nanoplatforms for MRSA Detection and Destruction from Whole Blood, Part. Part. Sys. Character., 2014, 31, 357-364.
117. Singh, A; Poshtiban, S; Evoy, S. Recent advances in Bacteriophage based Biosensors for Food-borne Pathogen Detection, Sensors, 2012, 13, 1763-1786.
118. Singh, R; Mukherjee, MD; Sumana, G; Gupta, RK; Sood, S; Malhotra, BD. Biosensors for pathogen detection: A smart approach towards clinical diagnosis, Sensor. Actuat. B: Chem., 2014, 197, 385-404.
119. Lansdown, A; Williams, A; Chandler, S; Benfield, S. Silver absorption and antibacterial efficacy of silver dressings, J. Wound Care, 2005, 14, 155-60.
120. Lansdown, ABG. A review of the use of silver in wound care: facts and fallacies, Br. J. Nurs., 2004, 13, S6-S19.
121. Dowsett, C. The use of silver-based dressings in wound care, Nurs. Stand., 2004, 19, 56-60.
122. Silvestry-Rodriguez, N; Sicairos-Ruelas, EE; Gerba, CP; Bright, KR. Silver as a disinfectant, Rev. Environ. Contam. Toxicol., 2007, 191, 23-45.
123. Lea, MC. Allotropic forms of silver, Am. J. Sci., 1889, 37, 476-491.
124. Height, MJ. In Presentation "Health Risk Assessment of Nanosilver" Workshop; Federal Institute for Risk Assessment (BfR): Berlin Marienfelde, 2011, Vol., 2014.
125. Jain, J; Arora, S; Rajwade, JM; Omray, P; Khandelwal, S; Paknikar, KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use, Mol. Pharm., 2009, 6, 1388-1401.
126. Seltenrich, N. Nanosilver: Weighing the Risks and Benefits; Environ. Health Perspect., 2013, 121, a220-225.
127. ATSDR In Agency for toxic substances and disease registry, ATSDR, USA: Atlanta, GA, 1997, Vol., 2014.
128. Nowack, B; Krug, HF; Height, M. 120 years of nanosilver history: implications for policy makers, Environ. Sci. Technol., 2011, 45, 1177-1183.
129. Wijnhoven, SWP; Peijnenburg, WJGM; Herberts, CA; Hagens, WI; Oomen, AG; Heugens, EHW; Roszek, B; Bisschops, J; Gosens, I; Van De Meent, D; Dekkers, S; De Jong, WH; van Zijverden, M; Sips, AJAM; Geertsma, RE. Nanosilver: A review of available data and knowledge gaps in human and environmental risk assessment, Nanotoxicology, 2009, 3, 109-138.
130. McShan, D; Ray, PC; Yu, H. Molecular toxicity mechanism of nanosilver, J. Food. Drug. Anal., 2014, 22, 116-127.
131. Paladini, F; De Simone, S; Sannino, A; Pollini, M. Antibacterial and antifungal dressings obtained by photochemical deposition of silver nanoparticles, J. Appl. Polym. Sci., 2014, 131, Online Publication.
132. Khaydarov, RR; Khaydarov, RA; Estrin, Y; Evgrafova, S; Scheper, T; Endres, C; Cho, S. In Nanomaterials: Risks and benefits; Springer, 2009.
133. Lara, HH; Garza-Trevino, EN; Ixtepan-Turrent, L; Singh, DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds, J. Nanobiotechnol., 2011, 9, 30.
134. Windler, L; Height, M; Nowack, B. Comparative evaluation of antimicrobials for textile applications, Environ. Int., 2013, 53, 62-73.
135. Zhang, F; Wu, X; Chen, Y; Lin, H. Application of silver nanoparticles to cotton fabric as an antibacterial textile finish, Fiber. Polym., 2009, 10, 496-501.
136. Monteiro, DR; Gorup, LF; Silva, S; Negri, M; de Camargo, ER; Oliveira, R; Barbosa, DB; Henriques, M. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata, Biofouling, 2011, 27, 711-719.
137. Choi, O; Yu, C-P; Esteban Fernández, G; Hu, Z. Interactions of nanosilver with Escherichia coli cells in planktonic and biofilm cultures, Water Res., 2010, 44, 6095-6103.
138. Newsome, R. IFT International Food Nanoscience Conference: Proceedings, Comp. Revs. Food Sci. Food Saf., 2013, 13, 190-228.
139. Costa, C; Conte, A; Buonocore, GG; Del Nobile, MA. Antimicrobial silvermontmorillonite nanoparticles to prolong the shelf life of fresh fruit salad, Int. J. Food. Microbiol., 2011, 148, 164-167.
140. Feng, QL; Wu, J; Chen, GQ; Cui, FZ; Kim, TN; Kim, JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus, J. Biomed. Mater. Res., 2000, 52, 662-668.
141. Spacciapoli, P; Buxton, D; Rothstein, D; Friden, P. Antimicrobial activity of silver nitrate against periodontal pathogens, J. Periodontal. Res., 2001, 36, 108-113.
142. Matsumura, Y; Yoshikata, K; Kunisaki, S-i; Tsuchido, T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate; Appl. Environ. Microbiol., 2003, 69, 4278-4281.
143. Sondi, I; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria, J. Coll. Interf. Sci., 2004, 275, 177-182.
144. Pal, S; Tak, YK; Song, JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli, Appl. Environ. Microbiol., 2007, 73, 1712-1720.
145. Butkus, MA; Labare, MP; Starke, JA; Moon, K; Talbot, M. Use of aqueous silver to enhance inactivation of coliphage MS-2 by UV disinfection, Appl. Environ. Microbiol., 2004, 70, 2848-2853.
146. Yamanaka, M; Hara, K; Kudo, J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis, Appl. Environ. Microb., 2005, 71, 7589-7593.
147. Shahverdi, AR; Fakhimi, A; Shahverdi, HR; Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli, Nanomed. Nanotechnol., 2007, 3, 168-171.
148. Gong, P; Li, H; He, X; Wang, K; Hu, J; Tan, W; Zhang, S; Yang, X. Preparation and antibacterial activity of Fe3O4@Ag nanoparticles, Nanotechnology, 2007, 18, 285604.
149. Jia, J; Duan, Y-y; Wang, S-h; Zhang, S-f; Wang, Z-y. Preparation and Characterization of Antibacterial Silver-containing Nanofibers for Wound Dressing Applications, J. US China Med. Sci., 2007, 4, 52-54.
150. Maneerung, T; Tokura, S; Rujiravanit, R. Impregnation of silver nanoparticles into bacterial cellulose for antimicrobial wound dressing, Carbohyd. Polym., 2008, 72, 43-51.
151. Ingle, A; Gade, A; Pierrat, S; Sonnichsen, C; Rai, M. Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria, Curr. Nanosci., 2008, 4, 141-144.
152. Geethalakshmi, R; Sarada, DVL. Synthesis of Plant-mediated Silver nanoparticles using Trianthema decandra Extract and Evaluation of their Anti microbial activities, Int. J. Eng. Sci. Technol., 2010, 2, 970-975.
153. Bonde, SR; Rathod, DP; Ingle, AP; Ade, RB; Gade, AK; Rai, MK. Murraya koenigiimediated synthesis of silver nanoparticles and its activity against three human pathogenic bacteria, Nanosci. Meth., 2011, 1, 25-36.
154. Govindaraju, K; Tamilselvan, S; Kiruthiga, V; Singaravelu, G. Biogenic silver nanoparticles by Solanum torvum and their promising antimicrobial activity, J. Biopest., 2010, 3, 394-399.
155. Namasivayam, S; Chitrakala, K. Ecotoxicological effect of Lecanicillium lecanii (Ascomycota: Hypocreales) based silver nanoparticles on growth parameters of economically important plants, J. Biopest., 2011, 4, 97-101.
156. Nam, K-Y. In vitro antimicrobial effect of the tissue conditioner containing silver nanoparticles, J. Adv. Prosthodont., 2011, 3, 20-24.
157. EI-Badawy, A; Feldhake, D; Venkatapathy, R. "State of the Science Literature Review: Everything Nanosilver and More," Environmental Protection Agency, Office of Research and Development, 2010.
158. Rai, M; Yadav, A; Gade, A. Silver nanoparticles as a new generation of antimicrobials, Biotech. Adv., 2009, 27, 76-83.
159. Shrivastava, S; Bera, T; Roy, A; Singh, G; Ramachandrarao, P; Dash, D. Characterization of enhanced antibacterial effects of novel silver nanoparticles, Nanotechnology, 2007, 18, 225103.
160. Liang, Z; Das, A; Hu, Z. Bacterial response to a shock load of nanosilver in an activated sludge treatment system, Water Res., 2010, 44, 5432-5438.
161. Likus, W; Bajor, G; Siemianowicz, K. Nanosilver - does it have only one face?, Acta Biochim. Pol., 2013, 60, 495.
162. Rizzello, L; Pompa, PP. Nanosilver-based antibacterial drugs and devices: Mechanisms, methodological drawbacks, and guidelines, Chem. Soc. Rev., 2014, 43, 1501-1518.
163. Kim, SW; Kim, KS; Lamsal, K; Kim, Y-J; Kim, SB; Jung, M; Sim, S-J; Kim, H-S; Chang, S-J; Kim, JK; Lee, YS. An in vitro study of the antifungal Effect of Silver Nanoparticles on oak Wilt Pathogen Raffaelea sp, J. Microbiol. Biotechnol., 2009, 19, 760-764.
164. Kim, K-J; Sung, W.S; Moon, S-K; Choi, J-S; Kim, J. G; Lee, D. G. Antifungal effect of silver nanoparticles on dermatophytes, J. Microbiol. Biotechnol., 2008, 18, 1482-4.
165. Panacek, A; Kolar, M; Vecerova, R; Prucek, R; Soukupov, J; Krystof, V; Hamal, P; Zboril, R; Kvítek, L. Antifungal activity of silver nanoparticles against Candida spp, Biomaterials, 2009, 30, 6333-6340.
166. Choi, O; Deng, KK; Kim, N-J; Ross Jr, L; Surampalli, RY; Hu, Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth, Water Res, 2008, 42, 3066-3074.
167. Prucek, R; Tucek, J; Kilianova, M; Panacek, A; Kvitek, L; Filip, J; Kolar, M; Tomankova, K; Zboril, R. The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles, Biomaterials, 2011, 32, 4704-4713.
168. Jo, Y-K; Kim, BH; Jung, G. Antifungal activity of silver ions and nanoparticles on phytopathogenic fungi, Plant Disease, 2009, 93, 1037-1043.
169. Nair, LS; Laurencin, CT. Silver nanoparticles: synthesis and therapeutic applications, J. Biomed. Nanotechnol., 2007, 3, 301-316.
170. Nasrollahi, A; Pourshamsian, KH; Mansourkiaee, P. Antifungal activity of silver nanoparticles on some of fungi, Int. J. Nano. Dimension, 2011, 1, 233-239.
171. Nadworny, PL; Wang, J; Tredget, EE; Burrell, RE. Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model, Nanomed. Nanotechnol., 2008, 4, 241-251.
172. Elechiguerra, JL; Burt, JL; Morones, JR; Camacho-Bragado, A; Gao, X; Lara, HH; Yacaman, MJ. Interaction of silver nanoparticles with HIV-1, J. Nanobiotechnol., 2005, 3, 1-10.
173. Marimuthu, S; Rahuman, AA; Rajakumar, G; Santhoshkumar, T; Kirthi, AV; Jayaseelan, C; Bagavan, A; Zahir, AA; Elango, G; Kamaraj, C. Evaluation of green synthesized silver nanoparticles against parasites, Parasitol. Res., 2011, 108, 1541-1549.
174. Yoon, K-Y; Hoon Byeon, J; Park, J-H; Hwang, J. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles, Sci. Tot. Environ., 2007, 373, 572-575.
175. Sadhasivam, S; Shanmugam, P; Yun, KS. Biosynthesis of silver nanoparticles by Streptomyces hygroscopicus and antimicrobial activity against medically important pathogenic microorganisms, Coll. Surf. B: Biointerf., 2010, 81, 358-362.
176. Nanda, A; Saravanan, M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE, Nanomed. Nanotechnol., 2009, 5, 452-456.
177. Jo, Y-K; Kim, BH; Jung, G. Antifungal activity of silver ions and nanoparticles on phytopathogenic fungi, Plant Dis., 2009, 93, 1037-1043.
178. Persing, T. A Multipronged Approach to Vancomycin-Resistant Enterococcus Control in an Acute-Care Setting, AJIC, 2004, 32, E19-E20.
179. Kon, K. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents, Expert Rev. Anti Infect. Ther., 2011, 9, 1035-1052.
180. Kathiresan, K; Alikunhi, NM; Pathmanaban, S; Nabikhan, A; Kandasamy, S. Analysis of antimicrobial silver nanoparticles synthesized by coastal strains of Escherichia coli and Aspergillus niger, Can. J. Microbiol., 2010, 56, 1050-1059.
181. Dehkordi, SH; Hosseinpour, F; Kahrizangi, AE. An in vitro evaluation of antibacterial effect of silver nanoparticles on Staphylococcus aureus isolated from bovine subclinical mastitis, Afr. J. Biotechnol., 2011, 10, 10795-10797.
182. Cui, L; Chen, P; Chen, S; Yuan, Z; Yu, C; Ren, B; Zhang, K. In Situ Study of the Antibacterial Activity and Mechanism of Action of Silver Nanoparticles by Surface-Enhanced Raman Spectroscopy, Anal. Chem., 2013, 85, 5436-5443.
183. Hsin, Y-H; Chen, C-F; Huang, S; Shih, T-S; Lai, P-S; Chueh, P. J. The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells, Toxicol. Lett., 2008, 179, 130-139.
184. Ivask, A; ElBadawy, A; Kaweeteerawat, C; Boren, D; Fischer, H; Ji, Z; Chang, CH; Liu, R; Tolaymat, T; Telesca, D. Toxicity Mechanisms in Escherichia coli Vary for Silver Nanoparticles and Differ From Ionic Silver, ACS nano, 2014, 8, 374-386.
185. Lansdown, ABG; Silver, I. its antibacterial properties and mechanism of action, J. Wound Care, 2002, 11, 125-131.
186. Li, W-R; Xie, X-B; Shi, Q-S; Zeng, H-Y; You-Sheng, O-Y; Chen, Y-B. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli, Appl. Microbiol. Biotech., 2010, 85, 1115-1122.
187. Prabhu, S; Poulose, EK. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects, Int. Nano Lett., 2012, 2, 1-10.
188. Lu, W; Senapati, D; Wang, S; Tovmachenko, O; Singh, AK; Yu, H; Ray, PC. Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes, Chem. Phys. Lett., 2010, 487, 92-96.
189. Lok, C-N; Ho, C-M; Chen, R; He, Q-Y; Yu, W-Y; Sun, H; Tam, PK-H; Chiu, J-F; Che, C-M. Proteomic analysis of the mode of antibacterial action of silver nanoparticles, J. Proteome Res., 2006, 5, 916-924.
190. Xiu, Z-M; Zhang, Q-B; Puppala, HL; Colvin, VL; Alvarez, PJJ. Negligible particlespecific antibacterial activity of silver nanoparticles, NanoLett., 2012, 12, 4271-4275.
191. Guzman, M; Dille, J; Godet, S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria, Nanomed. Nanotech. Biol. Med, 2012, 8, 37-45.
192. Bondarenko, O; Ivask, A; Käkinen, A; Kurvet, I; Kahru, A. Particle-cell contact enhances antibacterial activity of silver nanoparticles, PloS One, 2013, 8, e64060.
193. Sinha, R; Karan, R; Sinha, A; Khare, SK. Interaction and nanotoxic effect of ZnO and Ag nanoparticles on mesophilic and halophilic bacterial cells, Bioresource. Technol., 2011, 102, 1516-1520.
194. Khan, SS; Mukherjee, A; Chandrasekaran, N. Studies on interaction of colloidal silver nanoparticles (SNPs) with five different bacterial species, Colloids Surf. B, 2011, 87, 129-138.
195. Sedlak, RH; Hnilova, M; Grosh, C; Fong, H; Baneyx, F; Schwartz, D; Sarikaya, M; Tamerler, C; Traxler, B. Engineered Escherichia coli silver-binding periplasmic protein that promotes silver tolerance; Appl. Environ. Microbiol., 2012, 78, 2289-2296.
196. Lee, H-H; Chou, K-S; Huang, K-C. Inkjet printing of nanosized silver colloids, Nanotechnology, 2005, 16, 2436.
197. Samberg, ME; Orndorff, PE; Monteiro-Riviere, NA. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods, Nanotoxicology, 2011, 5, 244-253.
198. Wong, KKY; Liu, X. Silver nanoparticles - The real "silver bullet" in clinical medicine?, Med. Chem. Commun., 2010, 1, 125-131.
199. El Badawy, AM; Scheckel, KG; Suidan, M; Tolaymat, T. The impact of stabilization mechanism on the aggregation kinetics of silver nanoparticles, Sci. Total. Environ., 2012, 429, 325-331.
200. Verma, A; Stellacci, F. Effect of Surface Properties on Nanoparticle-Cell Interactions; Small, 2009, 6, 12-21.
201. Badawy, AME; Silva, RG; Morris, B; Scheckel, KG; Suidan, MT; Tolaymat, TM. Surface charge-dependent toxicity of silver nanoparticles, Environ. Sci. Technol., 2013, 45, 283-287.
202. Jang, J; Oh, JH. Facile Fabrication of Photochromic Dye- Conducting Polymer Core-Shell Nanomaterials and Their Photoluminescence, Adv. Mater., 2003, 15, 977-980.
203. Kang, S; Mauter, MS; Elimelech, M. Physicochemical determinants of multiwalled carbon nanotube bacterial cytotoxicity; Environ. Sci. Technol., 2008, 42, 7528-7534.
204. Kang, S; Mauter, MS; Elimelech, M. Microbial cytotoxicity of carbon-based nanomaterials: implications for river water and wastewater effluent, Environ. Sci. Technol., 2009, 43, 2648-2653.
205. Boxall, ABA; Tiede, K; Chaudhry, Q. Engineered nanomaterials in soils and water: how do they behave and could they pose a risk to human health?, Nanomed., 2007, 2, 919-927.
206. Park, HJ; Kim, JY; Kim, J; Lee, JH; Hahn, JS; Gu, MB; Yoon, J. Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity, Water Res., 2008, 43, 1027-1032.
207. Devi, LS; Joshi, S. Antimicrobial and synergistic effects of silver nanoparticles synthesized using soil fungi of high altitudes of eastern Himalaya, Mycobiology, 2012, 40, 27-34.
208. Chen, JC; Lin, ZH; Ma, XX. Evidence of the production of silver nanoparticles via pretreatment of Phoma sp. 3.2883 with silver nitrate, Lett. Appl. Microbiol., 2003, 37, 105-108.
209. Muhsin, TM; Hachim, AK. Mycosynthesis and characterization of silver nanoparticles and their activity against some human pathogenic bacteria, World J. Microb. Biotechnol., 2014, [Epub ahead of print], 1-10.
210. Kasten, B; Reski, R. b-Lactam antibiotics inhibit chloroplast division in a moss Physcomitrella patens but not in tomato Lycopersicon esculentum, J. Plant. Physiol., 1997, 150, 137-140.